✦ LIBER ✦

A phase Ib study investigating the combination of everolimus and dovitinib in vascular endothelial growth factor refractory clear cell renal cancer

✍ Scribed by Powles, Thomas; Foreshew, Shah-Jalal Sarker; Shamash, Jonathan; Sarwar, Naveed; Crabb, Simon; Sahdev, Anju; Nixon, Jude; Lim, Louise; Pungaliya, Ashish; Foreshaw, Abigail; Davies, Rachel; Greenwood, Michelle; Wilson, Peter; Pacey, Simon; Galazi, Myra; Jones, Robert; Chowdhury, Simon

Book ID: 124141146
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 566 KB
Volume: 50
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2014.04.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 2 study with a daily regimen of

A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer

✍ Robert J. Amato; Jaroslaw Jac; Sarah Giessinger; Somyata Saxena; James P. Willis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 2 views

Safety and efficacy of everolimus in Chi

Safety and efficacy of everolimus in Chinese patients with metastatic renal cell carcinoma resistant to vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: an open-label phase 1b study

✍ Jun Guo, Yiran Huang, Xu Zhang, Fangjian Zhou, Yinghao Sun, Shukui Qin… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 194 KB

Everolimus in metastatic renal cell carc

Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study

✍ E. Calvo; B. Escudier; R.J. Motzer; S. Oudard; T.E. Hutson; C. Porta; S. Bracard 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 262 KB

A Phase II Safety and Efficacy Study of

A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients With Metastatic Urothelial Cancer

✍ Pili, Roberto; Qin, Rui; Flynn, P.J.; Picus, Joel; Millward, Michael; Ho, Wing M 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 791 KB

A phase II study of the cancer vaccine T

A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings

✍ Stéphane Oudard; Olivier Rixe; Benoit Beuselinck; Claude Linassier; Eugeniu Banu 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 411 KB

UP-01.140 The Prognostic Value of C-Reac

UP-01.140 The Prognostic Value of C-Reactive Protein (CRP) in Regard to Cancer-Specific (CSS) and Overall Survival (OS) in Clear Cell Renal Cell Cancer (CCRCC) Patients May in Part Be Explained by Vascular Endothelial Growth Factor (VEGF)

✍ G. Gudbrandsdottir; K. Hjelle; H. Aarstad; L. Bostad; C. Beisland 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 67 KB